| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871664 | The Annals of Thoracic Surgery | 2016 | 8 Pages |
Abstract
The use of chemotherapy has significantly increased in patients with resected stage IB to IIIA NSCLC. Although clinicians have increasingly adopted evidence-based recommendations, significant treatment gaps persist and represent areas for quality improvement.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ravi MD, MSc, Jennifer L. MD, MS, Sanjay MD, MS, Jane L. MD, MPH, Karl Y. MD, MS, Clifford Y. MD, MSHS, David P. MD, Jyoti D. MD, Malcolm M. MD,